News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups
Hosted by Robert Michel

News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups
Hosted by Robert Michel
Sign In
Combating Antimicrobial Resistance: Aligning Policy, Advocacy, and Scientific Innovation

Combating Antimicrobial Resistance: Aligning Policy, Advocacy, and Scientific Innovation

Oct 14, 2024 | White Papers

White Paper, Combating Antimicrobial Resistance: Aligning Policy, Advocacy, and Scientific Innovation

Dark Daily’s free white paper, “Combating Antimicrobial Resistance: Aligning Policy, Advocacy, and Scientific Innovation” is for the laboratory community and has been produced in partnership with BioMerieux. It is available for free download.

Antimicrobial resistance (AMR) is a growing global health crisis that threatens human, animal, and environmental health. AMR results in higher rates of illness and death, as infections become increasingly difficult to manage, and it is projected to surpass cancer as the leading cause of death by 2050, underscoring the critical importance of addressing this issue across local, state, and global levels. In this paper we will discuss:

  • The interplay between policy, advocacy, and scientific advancements in combating AMR.
  • The role of diagnostics in identifying and controlling antimicrobial resistance.
  • The impact of patient advocacy on policy-making and healthcare outcomes.
  • Successful case studies of policy changes influenced by patient stories and scientific data.
  • Cross-functional collaboration as a catalyst for effective AMR strategies

This white paper serves as a practical guide to enhance the understanding of the POCT team regarding critical success factors and essential functions needed to sustain compliance and produce reliable results. It focuses on the tangible aspects of good laboratory practice and regulatory compliance in routine and urgent patient care settings. This resource will be particularly beneficial to nursing and other clinical staff involved in patient testing.

Click here to download the free white paper. For additional information inquire at info@darkreport.com, or call Amanda Curtis at 512-264-7103.

Published October 3, 2024
Produced in partnership with

BioMeriux
Guide to AI-Enabled Revenue Cycle Management for Molecular Diagnostics and Pathology Practices

Guide to AI-Enabled Revenue Cycle Management for Molecular Diagnostics and Pathology Practices

Oct 14, 2024 | White Papers

Dark Daily XiFin White Paper, Guide to AI-Enabled Revenue Cycle Management for Molecular Diagnostics and Pathology Practices

Dark Daily’s free white paper, “Guide to AI-Enabled Revenue Cycle Managment for Molecular Diagnostics and Pathology Practices” is for the laboratory community and has been produced in partnership with XiFin, Inc.  It is available for free download.

In today’s rapidly evolving healthcare landscape, molecular diagnostics and pathology laboratories face increasing challenges in maximizing revenue. Accurately estimating out-of-pocket costs and collecting payments efficiently can be challenging, often leading to delays and patient dissatisfaction. Additionally, ensuring timely and accurate claim submissions is crucial for maximizing revenue, but manual processes can be time-consuming and error-prone.

From complex billing processes to changing payer policies, the traditional revenue cycle management (RCM) approach is no longer sufficient, and maximizing revenue in this complex domain requires a comprehensive and strategic approach. By automating these tasks and streamlining the overall patient journey, healthcare providers can address these key pain points and improve their financial performance.

This white paper serves as a practical guide to enhance the understanding of the POCT team regarding critical success factors and essential functions needed to sustain compliance and produce reliable results. It focuses on the tangible aspects of good laboratory practice and regulatory compliance in routine and urgent patient care settings. This resource will be particularly beneficial to nursing and other clinical staff involved in patient testing.

Click here to download the free white paper. For additional information inquire at info@darkreport.com, or call Amanda Curtis at 512-264-7103.


Produced in partnership with

XIFIN The Power To Do Good
Best Practices in Molecular Assay Validation for Laboratory-Developed Tests

Best Practices in Molecular Assay Validation for Laboratory-Developed Tests

Feb 15, 2024 | White Papers

Seegene White Paper on Dark Daily website

Dark Daily’s free white paper, “Best Practices in Molecular Assay Validation for Laborator-Developed Tests,” is for the laboratory community and has been produced in partnership with Seegene USA. It is available for free download.

Molecular laboratory developed tests (LDTs) play a crucial role in providing accurate and timely patient care. These methods are designed to address those analytes or disease markers for which there is no commercially available test, so ensuring the safety and accuracy of these LDTs is not just an option – it’s a necessity.


This comprehensive white paper is designed to be your go-to guide, providing invaluable insights into critical success factors and essential functions crucial for maintaining compliance and delivering reliable results. Tailored for clinical molecular laboratory staff, this resource delves into the tangible aspects of compliant method validation, offering practical strategies for proving the accuracy and efficacy of laboratory-developed tests (LDTs).

Click here to download the free white paper. For additional information inquire at info@darkreport.com, or call Amanda Curtis at 512-264-7103.

Published February 15, 2024
Produced in partnership with

Seegene USA

Studies Show How Clinical Whole-Exome Sequencing May Forever Change the Future Practice of Medicine while Giving Pathologists a New Opportunity to Deliver Value

Apr 17, 2015 | Digital Pathology, Instruments & Equipment, Laboratory Instruments & Laboratory Equipment, Laboratory Management and Operations, Laboratory Pathology, Laboratory Testing

Similar study of exome sequencing at UCLA produces findings that mirror the diagnostic outcomes produced by researchers at the three Houston organizations

In recent years, pathologists and other clinical laboratory professionals have seen increasing evidence of the benefits of using exome sequencing for clinical diagnostic purposes.

Confirming their initial published findings of a 25% molecular diagnostic rate, researchers from Baylor College of Medicine (BCM), Baylor Human Genome Center, and the University of Texas Health Science Center at Houston have released results of a large sampling of 2,000 consecutive patients.

In this expanded study, published in the November 12, 2014, issue of the Journal of the American Medical Association (JAMA), 504 patients (25.2%) received a molecular diagnosis and 92 patients (4.6%) benefitted from medical intervention to ameliorate or eliminate negative symptoms. (more…)

In Boston this week, the Association of Pathology Chairs Looks at Healthcare’s Transformation and How It May Reshape Laboratory Medicine

Jul 12, 2013 | Compliance, Legal, and Malpractice, Digital Pathology, Instruments & Equipment, Laboratory Hiring & Human Resources, Laboratory Instruments & Laboratory Equipment, Laboratory News, Laboratory Operations, Management & Operations

Departments of pathology and clinical laboratory medicine at nation’s academic medical centers are uniquely positioned to deliver value—but only if they act in a timely fashion

DATELINE: BOSTON, MASSACHUSETTS—Today the Association of Pathology Chairs (APC) concluded its annual meeting, and transformation of the U.S. healthcare systems was front and center as the topic of primary interest. This transformation presents pathology departments at the nation’s academic centers with a range of unique opportunities, along with some serious challenges.

On the upside, academic departments of pathology and clinical laboratory medicine are well positioned to be the leaders in clinical diagnostics that utilize the latest genetic knowledge and incorporate state-of-the-art molecular technologies. Not only are they teaching this knew knowledge to the next generation of physicians and pathologists, they are often the only locally based laboratory organization in a city or region that offers these advanced medical laboratory testing services. (more…)

;